Liposomal daunorubicin (DaunoXome) for treatment of relapsed meningeal acute myeloid leukemia

被引：0
|
作者：
PP Piccaluga
G Visani
G Martinelli
A Isidori
M Malagola
M Rondoni
M Baccarani
S Tura
机构：
[1] Institute of Haematology and Clinical Oncology,Department of Hematology
[2] ‘L and A Seràgnoli’,undefined
[3] University of Bologna,undefined
[4] S Salvatore Hospital,undefined
来源：
Leukemia | 2002年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1880 / 1881
页数：1
相关论文
共 50 条
  • [31] Treatment of Relapsed Acute Myeloid Leukemia
    Felicitas Thol
    Arnold Ganser
    [J]. Current Treatment Options in Oncology, 2020, 21
  • [32] Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children
    Reinhardt, D
    Hempel, G
    Fleischhack, G
    Schulz, A
    Boos, J
    Creutzig, U
    [J]. KLINISCHE PADIATRIE, 2002, 214 (04): : 188 - 194
  • [33] Treatment of newly diagnosed acute myelogenous leukemia adults younger than age 56 with liposomal daunorubicin (DaunoXome) and ARA-C.
    Douer, D
    Mohrbacher, A
    Watkins, K
    Rutledge, P
    Onetto, N
    Levine, A
    [J]. BLOOD, 2001, 98 (11) : 211B - 212B
  • [34] Treatment of newly diagnosed acute myelogenous leukemia adults younger than age 55 with liposomal daunorubicin (DaunoXome) and ARA-C.
    Douer, D
    Mohrbacher, A
    Watkins, K
    Rutledge, P
    Onetto, N
    [J]. BLOOD, 2000, 96 (11) : 210B - 210B
  • [35] Assessing Efficacy and Safety of Daunorubicin and Cytarabine Liposomal in Patients with Acute Myeloid Leukemia
    Rogers, Elizabeth
    Hibino, Maho
    Hunt, Rebecca Garcia
    Ellis, Leslie Renee
    Bhave, Rupali
    Howard, Dianna S.
    Lyerly, Susan
    Dralle, Sarah
    Manuel, Megan
    Pardee, Timothy S.
    Powell, Bayard L.
    [J]. BLOOD, 2019, 134
  • [36] Phase I study of liposomal daunorubicin (Daunoxome) in the treatment of metastatic breast cancer
    Thomas, A
    Shields, F
    Wells-Jordan, P
    Lloyd, D
    Hubbard, A
    Steward, WP
    O'Byrne, KJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S293 - S293
  • [37] Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
    Kaspers, Gertjan J. L.
    Zimmermann, Martin
    Reinhardt, Dirk
    Gibson, Brenda E. S.
    Tamminga, Rienk Y. J.
    Aleinikova, Olga
    Armendariz, Hortensia
    Dworzak, Michael
    Ha, Shau-Yin
    Hasle, Henrik
    Hovi, Liisa
    Maschan, Alexei
    Bertrand, Yves
    Leverger, Guy G.
    Razzouk, Bassem I.
    Rizzari, Carmelo
    Smisek, Petr
    Smith, Owen
    Stark, Batia
    Creutzig, Ursula
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (05) : 599 - 607
  • [38] Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study
    van Eijkelenburg, Natasha K. A.
    Rasche, Mareike
    Ghazaly, Essam
    Dworzak, Michael N.
    Klingebiel, Thomas
    Rossig, Claudia
    Leverger, Guy
    Stary, Jan
    De Bont, Eveline S. J. M.
    Chitu, Dana A.
    Bertrand, Yves
    Brethon, Benoit
    Strahm, Brigitte
    van der Sluis, Inge M.
    Kaspers, Gertjan J. L.
    Reinhardt, Dirk
    Zwaan, C. Michel
    [J]. HAEMATOLOGICA, 2018, 103 (09) : 1484 - 1492
  • [39] Efficacy and toxicity of the FLAG/Daunoxome® association in children with relapsed or resistant acute myeloid leukemia (AML).
    Rizzari, C
    Micalizzi, C
    Locatelli, F
    Maffeis, B
    Daldossi, S
    Ladogana, S
    Casale, F
    Fagioli, F
    Lippi, A
    Colombini, A
    Pession, A
    [J]. BLOOD, 2002, 100 (11) : 344A - 344A
  • [40] 2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia
    Van den Neste, E
    Martiat, P
    Mineur, P
    Delannoy, A
    Doyen, C
    Zenebergh, A
    Michaux, JL
    Ferrant, A
    [J]. ANNALS OF HEMATOLOGY, 1998, 76 (01) : 19 - 23
12345